【財華社訊】港交所權益資料顯示,昭衍新藥(06127.HK)獲Aggregate of abrdn plc affiliated investment management entities於2月25日在場內以每股平均價65.4785港元增持100萬股,涉資約6547.85萬港元。增持後,Aggregate of abrdn plc affiliated investment management entities的最新持股數目為512.29萬股,持股比例由6.79%增持至8.44%。(出處:FinetAI)
港交所原文